We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+15.56%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$883B
AUM Growth
+$71.1B
Cap. Flow
-$18.1B
Cap. Flow %
-2.06%
Top 10 Hldgs %
35.83%
Holding
3,193
New
153
Increased
2,010
Reduced
803
Closed
136

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.94B
2
AVGO icon
Broadcom
AVGO
+$2.74B
3
MSFT icon
Microsoft
MSFT
+$2.33B
4
AMD icon
Advanced Micro Devices
AMD
+$1.47B
5
GE icon
GE Aerospace
GE
+$1.27B

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.42B
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.44B
3
AAPL icon
Apple
AAPL
+$2.42B
4
FISV
Fiserv Inc
FISV
+$2.3B
5
LLY icon
Eli Lilly
LLY
+$1.78B

Sector Composition

Rank Sector Weight
1 Technology 34.73%
2 Financials 12.11%
3 Healthcare 10.97%
4 Consumer Discretionary 10.95%
5 Communication Services 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAUX
3076
i-80 Gold Corp
IAUX
$1.51B
– –
-142,048
Closed -$83K
IMRX icon
3077
Immuneering
IMRX
$276M
– –
-659,009
Closed -$1M
INMD icon
3078
InMode
INMD
$821M
– –
-28,348
Closed -$503K
INO icon
3079
Inovio Pharmaceuticals
INO
$122M
– –
-15,601
Closed -$26K
INZY
3080
DELISTED
Inozyme Pharma
INZY
– –
-19,533
Closed -$18K
IPSC icon
3081
Century Therapeutics
IPSC
$302M
– –
-14,882
Closed -$8K
IVVD icon
3082
Invivyd
IVVD
$275M
– –
-35,716
Closed -$22K
IVW icon
3083
iShares S&P 500 Growth ETF
IVW
$78.8B
– –
-3,836
Closed -$356K
JWN
3084
DELISTED
Nordstrom
JWN
– –
-68,534
Closed -$1.68M
KNSA icon
3085
Kiniksa Pharmaceuticals
KNSA
$5.86B
– –
-16,755
Closed -$373K
LCTX icon
3086
Lineage Cell Therapeutics
LCTX
$260M
– –
-72,398
Closed -$33K
LNZA icon
3087
LanzaTech
LNZA
$78.9M
– –
-523
Closed -$13K
LSEA
3088
DELISTED
Landsea Homes
LSEA
– –
-12,433
Closed -$80K
LVO icon
3089
LiveOne
LVO
$32.1M
– –
-3,595
Closed -$26K
LXRX icon
3090
Lexicon Pharmaceuticals
LXRX
$796M
– –
-92,248
Closed -$43K
LYG icon
3091
Lloyds Banking Group
LYG
$83.2B
– –
-902,437
Closed -$3.45M
LYRA
3092
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-351
Closed -$3K
MGNX icon
3093
MacroGenics
MGNX
$238M
– –
-25,652
Closed -$33K
KG
3094
Kestrel Group
KG
$39.4M
– –
-3,402
Closed -$39K
MKTW icon
3095
MarketWise
MKTW
$56.8M
– –
-802
Closed -$8K
MRSN
3096
DELISTED
Mersana Therapeutics
MRSN
– –
-2,484
Closed -$22K
MUFG icon
3097
Mitsubishi UFJ Financial
MUFG
$264B
– –
-327,806
Closed -$4.47M
MURA
3098
DELISTED
Mural Oncology
MURA
– –
-26,905
Closed -$34K
NAUT icon
3099
Nautilus Biotechnolgy
NAUT
$123M
– –
-16,078
Closed -$14K
NGG icon
3100
National Grid
NGG
$75.9B
– –
-67,965
Closed -$4.27M

Similar funds

T. Rowe Price Associates's Q2 2025 Portfolio in Review

As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
  • T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
  • T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
  • T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
  • T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
  • T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
  • T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.